Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 13(1): 15576, 2023 09 20.
Article in English | MEDLINE | ID: mdl-37730859

ABSTRACT

Cancer is one of the leading causes of death, which has attracted the attention of the scientific world to the search for efficient methods for treatment. With the great development and regeneration of nanotechnology over the last 25 years, various nanoparticles in different structures, shapes and composites provide good potential for cancer therapy. There are several drugs approved by FDA used in breast cancer treatment like Cyclophosphamide, Doxorubicin Hydrochloride, Femara, Herceptin, etc. Each has several side effects as well as treatment, which limits the use of drugs due to heart failure, pulmonary dysfunction, or immunodeficiency. Recently, such side effects are greatly reduced by using innovative delivery techniques. Some drugs have been approved for use in cancer treatment under the concept of drug delivery, such as Doxil (liposomal loaded doxorubicin). The purpose of this study is to investigate the effect of copper nanoparticles (CuNPs) as a drug model for cancer treatment, either in their free form or encapsulated in Soy lecithin liposomes (SLP) from plant origin as a cheap source of lipids. CuNPs were prepared by the chemical reduction method and loaded onto SLP through the thin film hydration method. The drug model Cu/SLP was successfully combined. The characteristics of the free CuNPs, liposomes, and the combined form, zeta potential, size distribution, drug encapsulation efficiency (EE%), drug release profile, Fourier transform infrared (FTIR), and transmission electron microscopy (TEM), were checked, followed by an in vitro study on the breast cancer cell line Mcf-7 as a model for cytotoxicity evaluation. The optimal Cu/SLP had a particle mean size of 81.59 ± 14.93 nm, a negative zeta potential of - 50.7 ± 4.34 mV, loaded CuNPs showed an EE% of 78.9%, a drug release profile for about 50% of the drug was released after 6 h, and FTIR analysis was recorded. The cytotoxicity assay showed that the IC50 of Cu/SLP is smaller than that of free CuNPs. These results give clear evidence of the efficacy of using the combined Cu/SLP rather than CuNPs alone as a model drug carrier prepared from plant origin against cancer, both medically and economically.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Neoplasms , Humans , Liposomes , Copper , Lecithins , MCF-7 Cells , Drug Delivery Systems
2.
Prog Biophys Mol Biol ; 140: 142-149, 2018 12.
Article in English | MEDLINE | ID: mdl-29885346

ABSTRACT

It has been found that medicinal plants have chemical and/or therapeutic effects on different diseases related to oxidative damage. This work investigates the use of ethanolic Moringa oleifera leaves extract; as a protective and/or therapeutic agent against damage induced by high acute dose of ionizing radiation. Also, this study aims to explore the associations of electrical properties (relaxation time and DC conductivity of bone marrow) with biochemical markers (SOD, CAT and GSH) to detect and prognosticate radiation effects. Biophysical and biochemical data revealed that Moringa extract can improve the electrical properties of bone marrow and the antioxidants levels in the blood. They also showed that the feeding of Moringa leaves extract post irradiation is preferred to recover rapidly and continuously from radiation effects.


Subject(s)
Moringa oleifera/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Radiation-Protective Agents/pharmacology , Animals , Antioxidants/metabolism , Bone Marrow/drug effects , Bone Marrow/metabolism , Bone Marrow/radiation effects , Catalase/metabolism , Electric Impedance , Female , Glutathione/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/metabolism
3.
Prog Biophys Mol Biol ; 140: 124-132, 2018 12.
Article in English | MEDLINE | ID: mdl-29776659

ABSTRACT

The response of adult Wistar albino female rats toward two dose rates of gamma radiation delivered as acute dose of 7 Gy is investigated using classical methodologies as chemical, hematological and histological parameters in comparison with newly introduced dielectric parameters. Two groups of rats were exposed to γ ray with dose rates 533.35 mGy/min and 325.89 mGy/min. Then the irradiated groups were followed up for two weeks after irradiation. In case of higher dose rate, high percentage of animals was lost and there were substantial alterations in the dielectric parameters in addition to massive damage in liver and bone marrow cells. On the other hand, a reduction of death rate of rats, different behavior in the dielectric parameters of bone marrow and lesser injury of liver tissue were well noticeable in case of lower dose rate. Moreover, the sensitivity of dielectric parameters toward the two different dose rates was well pronounced during the 1st and 2nd weeks after irradiation more than other parameters.


Subject(s)
Bone Marrow/radiation effects , Radiation Dosage , Animals , Dose-Response Relationship, Radiation , Electric Impedance , Female , Gamma Rays/adverse effects , Hematologic Tests , Liver/immunology , Liver/radiation effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...